MULTICENTER RANDOMIZED PHASE II STUDY OF R-MPV-A CHEMOIMMUNOTHERAPY WITH OR WITHOUT LOW-DOSE WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: NRG/ RTOG 1114 Other Scholarly Work

Omuro, A, Deangelis, L, Polley, MC et al. (2025). MULTICENTER RANDOMIZED PHASE II STUDY OF R-MPV-A CHEMOIMMUNOTHERAPY WITH OR WITHOUT LOW-DOSE WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: NRG/ RTOG 1114 . NEURO-ONCOLOGY, 27 iii15-iii16. 10.1093/neuonc/noaf193.045

Open Access International Collaboration

cited authors

  • Omuro, A; Deangelis, L; Polley, MC; Correa, D; Wefel, JS; Bovi, JA; Rosenblum, M; Corn, BW; Aneja, S; Grommes, C; Peereboom, DM; Lallana, E; Werner-Wasik, M; Rogers, C; Iwamoto, F; Yu, H; Donnelly, E; Struve, TD; Won, M; Mehta, MP

authors

publication date

  • October 1, 2025

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • iii15

end page

  • iii16

volume

  • 27